Atlas Trials

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Clinical trial NCT01222338 · COMPLETED

Trial details

NCT number
NCT01222338
Sponsor
Lisichansk Regional Tuberculosis Dispensary
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculosis
Start date
2010-01-01
Primary completion
2010-12-01
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.